FDA Greenlights Kythera’s Kybella
In a much anticipated approval, the FDA has given its nod to Kythera's Kybella to treat double chins.
In a much anticipated approval, the FDA has given its nod to Kythera's Kybella to treat double chins.
Autologous Spray-On Skin Cells are expanding what's possible in reconstructive surgery. By reducing donor skin requirements and supporting faster, more natural healing, the technology is helping surgeons improve both functional and aesthetic outcomes while reshaping the approach to burns, traumatic wounds, and complex reconstruction.